======= FUT3 ======= == Gene Information == * **Official Symbol**: FUT3 * **Official Name**: fucosyltransferase 3 (Lewis blood group) * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2525|2525]] * **UniProt**: [[https://www.uniprot.org/uniprot/P21217|P21217]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FUT3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FUT3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/111100|Open OMIM]] == Function Summary == * **Entrez Summary**: The Lewis histo-blood group system comprises a set of fucosylated glycosphingolipids that are synthesized by exocrine epithelial cells and circulate in body fluids. The glycosphingolipids function in embryogenesis, tissue differentiation, tumor metastasis, inflammation, and bacterial adhesion. They are secondarily absorbed to red blood cells giving rise to their Lewis phenotype. This gene is a member of the fucosyltransferase family, which catalyzes the addition of fucose to precursor polysaccharides in the last step of Lewis antigen biosynthesis. It encodes an enzyme with alpha(1,3)-fucosyltransferase and alpha(1,4)-fucosyltransferase activities. Mutations in this gene are responsible for the majority of Lewis antigen-negative phenotypes. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008]. Sequence Note: This RefSeq record represents the LE*01.01.01 allele. * **UniProt Summary**: May catalyze alpha-1,3 and alpha-1,4 glycosidic linkages involved in the expression of Vim-2, Lewis A, Lewis B, sialyl Lewis X and Lewis X/SSEA-1 antigens. May be involved in blood group Lewis determination; Lewis-positive (Le(+)) individuals have an active enzyme while Lewis-negative (Le(-)) individuals have an inactive enzyme. Also acts on the corresponding 1,4-galactosyl derivative, forming 1,3-L-fucosyl links. |Glyco transf 10| |3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity| |alpha-(1->3)-fucosyltransferase activity| |fucosyltransferase activity| |oligosaccharide biosynthetic process| |fucosylation| |oligosaccharide metabolic process| |cell-cell recognition| |ceramide metabolic process| |Golgi cisterna membrane| |carbohydrate biosynthetic process| |sphingolipid metabolic process| |membrane lipid metabolic process| |cell recognition| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |carbohydrate metabolic process| |Golgi membrane| |carbohydrate derivative biosynthetic process| |cellular amide metabolic process| |cellular lipid metabolic process| |carbohydrate derivative metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |membrane| \\ === CRISPR Data === No hits were found. ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.446| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4967 * **Expression level (log2 read counts)**: 0.47 {{:chemogenomics:nalm6 dist.png?nolink |}}